ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993

As von Eschenbach Prepares For New Assignment, NCI’s 2015 Goal Faces Uncertainty. New Strategic Plan Lists Steps to 2015. “The Vision Is Within Our Grasp,” von Eschenbach Says.

March 10, 2006

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001

John Niederhuber Named Acting NCI Director.

June 2, 2006

In Brief: Elion Elected Member Of National Academy; Bleyer Heads M.D. Anderson Pediatrics

May 4, 1990